Loading clinical trials...
Loading clinical trials...
RAISE is a multicenter randomized controlled trial to assess the efficacy of adjuvant radiotherapy for controlling postsurgical recurrence in HCC patients with narrow margin (≤ 1 cm) after curative re...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sun Yat-sen University
Collaborators
NCT07607769 · Hepatocellular Carcinoma
NCT06355050 · Prostate Cancer, Adaptive Radiotherapy, and more
NCT07610551 · HCC - Hepatocellular Carcinoma
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT05941741 · Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, and more
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions